— Know what they know.
Not Investment Advice

NYXH NASDAQ

Nyxoah S.A.
1W: -6.2% 1M: -9.9% 3M: -23.2% YTD: -69.8% 1Y: -72.5% 3Y: -80.8% 5Y: -95.6%
$1.36
+0.03 (+2.26%)
 
Weekly Expected Move ±13.5%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Medical - Specialties · Tech Score Sell · Power 31 · $136.1M mcap · 58M float · 0.611% daily turnover · Short 47% of daily vol

Cash Flow Trends

Operating Cash Flow
-$67M -37.1% ▼
Capital Expenditures
$805K +86.7% ▲
5Y CAGR: -40.4%
Free Cash Flow
-$68M -23.5% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$131K -101.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$25M-$30M-$45M-$56M-$90M
Depreciation & Amort.$2M$2M$2M$3M$4M
Stock-Based Comp.$1M$3M$3M$4M$0
Change in Working Capital-$1M$86K-$3M$3M$5M
Other Non-Cash Items-$2M-$3M-$2M-$2M$13M
Operating Cash Flow-$25M-$29M-$45M-$49M-$67M
— Investing Activities —
Capital Expenditures-$1M-$886K-$2M-$1M-$4M
Acquisitions (Net)$0$0$0$0$3K
Investment Purchases$0-$103M-$80M-$98M-$42M
Investment Sales$0$29M$121M$85M$72M
Other Investing-$10M-$15M-$6M-$3M$0
Investing Cash Flow-$12M-$90M$32M-$16M$26M
— Financing Activities —
Net Debt Issuance-$863K-$1M-$1M$8M$19M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$393K-$167K-$243K-$758K-$1M
Financing Cash Flow$76M-$983K$17M$77M$39M
Net Change in Cash$43M-$118M$4M$13M-$131K
Cash End of Period$136M$18M$22M$34M$30M
Free Cash Flow-$37M-$45M-$56M-$55M-$68M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms